R&D Tax Incentive Financing in Australia: How to Access Your Rebate Early

The Quick Version

  • R&D Tax Incentive financing is a loan secured against your expected R&DTI rebate, giving you access to up to 80% of the rebate before the ATO pays out
  • Lending is based on eligible R&D expenditure you’ve already incurred during the current financial year, not projections
  • The structure is non-dilutive, with no equity given up, no personal guarantees, and no restrictions on how the funds are used
  • The loan settles automatically when your R&DTI refund arrives from the ATO, with no monthly repayments in the interim
  • R&D finance doesn’t replace the R&DTI. You must be claiming or planning to claim the incentive to qualify

Your research and development (R&D) spend happens in real time. Salaries land every fortnight, contractor invoices arrive monthly, and cloud infrastructure costs don’t pause for the end of the financial year. The R&DTI refund, on the other hand, arrives as a lump sum from the ATO months after you lodge your return.

That gap between spending and receiving creates a very specific cash flow problem for R&D-active businesses. According to the Reserve Bank of Australia, one in five Australian SMEs still reports challenges when obtaining finance, and the most common barriers are strict collateral requirements, unsuitable interest rates, and long processing times. For companies already investing heavily in development, waiting six to 12 months for a refund they’ve already earned only compounds the pressure.

R&D Tax Incentive financing exists to close that gap. It’s one of the more targeted forms of R&D financing in Australia, and it works differently from most business lending products. It isn’t a grant, venture capital, or a line of credit secured against your house. It’s a loan against something you already own: the research and development tax rebate your eligible R&D expenditure has generated.

What is R&D Tax Incentive Financing?

R&D Tax Incentive financing is a short-term loan secured against a company’s expected R&DTI rebate. It allows businesses that are conducting eligible R&D to access up to 80% of their anticipated refund during the financial year, rather than waiting for the ATO to process the return and pay out after year-end.

The loan is repaid automatically when the ATO refund arrives, and there are no monthly repayments, no equity given up, and no restrictions on how the funds are spent. The entire structure is designed around one idea: you’ve already done the work and incurred the expenditure, so why should you wait another six to 12 months before that money becomes available?

To be clear on terminology: the Australian Government’s programme is technically a tax offset, not a tax credit, though you’ll often see the terms used interchangeably in the market. The distinction matters for how the benefit flows through your company tax return. If you’re claiming the development R&D tax credit equivalent in Australia (the R&DTI offset), a closer look at [the difference between R&D tax offsets and credits][CHILD BLOG URL: R&D Tax Offset vs R&D Tax Credit] will help clarify how your claim is calculated.

What R&D Tax Incentive financing does not do is replace the R&DTI itself. A company must be eligible for the incentive and must be planning to lodge a claim. The finance is secured against the expected rebate that the claim will generate. Think of it as bringing forward money the government already owes you, so you can put it to work sooner rather than leaving it parked in the ATO processing pipeline.

How Much of Your Rebate Can You Access?

Hands using a calculator next to a tablet and startup business paperwork to calculate an expected R&D tax refund.

Through R&D finance, a business can typically access up to 80% of its expected R&DTI rebate, calculated against eligible R&D expenditure already incurred during the current financial year.

Here’s how that looks in practice. A company with an aggregated turnover under $20 million and a 25% corporate tax rate receives a refundable offset of 43.5%. If that company has spent $1 million on eligible R&D activities so far this tax year, the expected rebate from the ATO is $435,000. At up to 80%, the company could access approximately $348,000 through R&D finance before the ATO pays out. That’s capital available now, not after year-end lodgment and processing.

Two important points about how the lending works. First, the amount is based on year-to-date expenditure already incurred and verified by your R&D tax consultant through a comfort letter. It is not based on projected spend or what you expect to invest later in the year. Rocking Horse lends against what you’ve already spent, confirmed by an independent advisor, which is why the finance can be arranged before your claim is lodged. Second, as your eligible R&D expenditure grows quarter by quarter, so does the amount you can potentially draw. Multiple drawdowns within the same financial year are available, meaning the facility grows alongside your R&D activity.

This section is about how much you can access early through finance. If you’re looking for a breakdown of how the R&DTI rebate itself is calculated and what the total refund could be worth, that’s a different question. [Our guide to calculating your R&D tax rebate][CHILD BLOG URL: R&D Tax Rebate How Much Can You Claim] covers the offset rates, intensity thresholds, and eligible expenditure categories in detail.

How the cash flow gap works

The R&DTI is genuinely valuable. For eligible companies under $20 million in turnover, the 43.5% refundable offset represents a meaningful return on investment in R&D, but the problem has never been the incentive itself. It’s the timeline between spending and receiving.

Consider the typical sequence for a company with a standard 30 June year-end. R&D expenditure begins accruing from 1 July, with salaries, contractor invoices, and materials costs landing throughout the year. Once the financial year closes, the company has until the following 30 April to register its R&D activities with DISR. It then lodges its company tax return with the ATO, and the refund arrives as a single payment after the return is processed. For expenditure incurred in July or August, the wait for that rebate can stretch well past 12 months, and even expenditure incurred in May or June of the same year won’t be refunded until well into the following calendar year.

That’s a long time to wait when the bills are already paid. A joint CommBank and UNSW survey published in January 2025 found that nearly 80% of Australian small and medium businesses had experienced significant cash flow impacts in the prior 12 months. Among those affected, 27% had used personal savings or skipped their own salary to keep things running. These are businesses that are already under pressure before the R&DTI timing gap enters the picture.

For an R&D-active company, this pressure takes a specific and compounding shape. The expenditure is real, ongoing, and often substantial, while the rebate sits locked in a processing pipeline that the company has no control over. R&D Tax Incentive financing bridges that timing mismatch by releasing capital that’s already been generated by the work you’ve done, so you can keep moving rather than waiting.

The compounding effect: Why accessing your rebate early pays off twice

Two female colleagues collaborating on a laptop in a modern office, planning how to reinvest their R&D capital.

Australian businesses spent $24.4 billion on R&D in 2023–24, an 18% increase from two years earlier, according to the Australian Bureau of Statistics. That growth is concentrated in sectors where speed matters most. Information and computing sciences accounted for 42% of total business R&D expenditure, and professional services recorded the largest dollar increase at $2.2 billion.

When capital is tied up waiting for a rebate, the cost is more than just forgone interest. It’s the development milestones that slip because a key hire gets pushed to next quarter. It’s the competitor who gets their product to market while your team is still waiting on a refund. And it’s the lost opportunity to reinvest early proceeds into the next phase of development. For companies making a sustained investment in R&D, early access to the rebate creates a compounding benefit: the capital you receive now funds the work that generates next year’s rebate, and the cycle builds on itself.

The Australian Government itself recognises this timing problem. The Ambitious Australia report, released as part of the Strategic Examination of Research and Development in March 2026, explicitly recommended quarterly advance payments based on the BAS to support cash flow for high-potential startups. The 2026–27 Federal Budget responded with significant proposed R&DTI reforms, including higher offset rates for core R&D activities and a broader turnover threshold for refundable offsets. EY’s analysis of the proposed changes described the package as a clear pivot toward incentivising core experimental R&D while improving fiscal sustainability. [Our breakdown of the proposed 2026 R&DTI reforms][CHILD BLOG URL: 2026 RDTI Budget Changes] covers what the changes mean for your claim. Those reforms are proposed for income years starting from 1 July 2028 and are subject to legislation, so until they take effect, R&D finance remains the primary mechanism for closing the gap.

Who is eligible for R&D finance?

Eligibility for R&D finance follows directly from eligibility for the R&DTI itself. If your company qualifies for the incentive and has incurred eligible R&D expenditure, you’re likely a candidate for R&DTI finance.

The core requirements are straightforward. Your business must be an Australian-incorporated company, or a foreign company carrying on business through a permanent establishment in Australia, that’s eligible for the R&D Tax Incentive. You must have already incurred eligible R&D expenditure during the current financial year, and you need a comfort letter from an R&D tax consultant confirming those expenses.

People often ask what qualifies for R&D tax credit purposes in Australia (remembering that the Australian equivalent is the R&DTI offset, not a credit). Eligible activities are those that involve generating new knowledge through a process of systematic experimentation to resolve genuine technical uncertainty. This covers a wide range of work across sectors, from software development and engineering to clinical trials and materials science. The key test is whether the outcome of the work couldn’t be determined in advance by a competent professional in the field.

If you don’t yet have an R&D advisor, Rocking Horse Group can connect you with one from their network of trusted consultants. This is a practical step that helps businesses explore R&D finance even if they haven’t previously claimed the R&DTI.

The R&DTI itself has a minimum spend threshold of $20,000 in eligible R&D notional deductions per income year, unless expenditure is to a registered Research Service Provider. Eligible expenditure includes employee salaries and on-costs for R&D work, contractor payments, materials and consumables, cloud and software costs related to R&D, and the decline in value of assets used in R&D activities. For a full walkthrough of what qualifies, our eligibility checklist covers each category in detail.

R&D finance is available from $50,000 to $10 million, making it relevant for early-stage startups through to large enterprises running multi-project R&D programmes across several financial years.

How the process works

Three smiling business professionals sitting in a modern office lounge reviewing an R&D finance application on a tablet.

The application process has six steps, and it’s designed to move quickly. Funds typically arrive within two weeks of approval.

It starts with a conversation. You contact the Rocking Horse team, and they assess whether your business and R&D activity are a fit. From there, it’s about documentation: gathering your supporting materials, including the comfort letter from your R&D tax consultant, confirming your ATO position is in order, and submitting the application. The comfort letter is a critical piece because it provides independent verification of the eligible expenditure your company has incurred, and it’s what the lending amount is calculated against. Once everything is in order and approved, funds are released.

There are no monthly repayments during the life of the loan. The facility settles automatically when the ATO pays your R&DTI refund, and there are no personal guarantees required and no restrictions on how the funds are used. Whether you reinvest in development, bring forward a hire, fund a product launch, or cover operational costs while the rebate makes its way through the system, that decision is entirely yours.

For businesses planning to use R&D finance on an ongoing basis, a multi-year facility agreement is available with rates set at a point lower than the single-year option. This suits companies that want to lock in terms across multiple R&D cycles and build the facility into their annual financial planning. The R&D financing page has a detailed walkthrough of the application steps and required documents.

R&D finance vs waiting for your rebate

There’s a straightforward case for simply waiting. The rebate costs nothing when the ATO pays it out on the standard timeline, and it involves no additional finance charges or paperwork beyond the claim itself. If your R&D expenditure is modest and your cash position is comfortable, waiting may well be the right call.

The trade-off becomes clear when the numbers get larger and the timelines get tighter. For businesses where capital is working hard, and development milestones are time-sensitive, six to 12 months of locked-up capital has a real cost even if it doesn’t appear on an invoice. A product launch delayed by a quarter, a senior developer hired three months late, or a clinical trial paused while the team waits on funding can all have consequences that extend well beyond the finance charge of accessing the rebate early.

R&D Tax Incentive financing gives you access to up to 80% of your expected rebate during the financial year, and the R&D loan is structured specifically for this situation. It requires no personal guarantees and repays automatically from the ATO refund when it arrives. Compared to raising equity, which dilutes your ownership permanently for capital you could have accessed through your own rebate, or taking a traditional business loan that typically requires property or personal collateral, R&D finance is built around a specific government-backed asset: the rebate your R&D expenditure has already generated.

The RBA’s October 2025 Bulletin on small business finance noted that while access to SME finance has improved, the most common barriers remain strict collateral requirements and difficulty securing suitable rates. R&D finance sidesteps both of those barriers because the collateral is the rebate itself. For companies that are already going through the R&DTI process and have confidence in their claim, the question isn’t whether the rebate will arrive. It’s whether you can afford to wait for it.

Real businesses, real results

Rocking Horse Group has helped businesses across sectors access their R&D rebates early, from early-stage startups to established companies running substantial R&D programmes. With Australian business R&D expenditure reaching $24.4 billion in 2023–24 and information and computing sciences accounting for 42% of that total, the companies using R&D finance span a wide range of industries and growth stages.

Find a Recruiter, an Australian recruitment technology company, used R&D finance to maintain development momentum without giving up equity or waiting for the ATO refund to arrive. Roster Right, a workforce management platform, accessed funding against its eligible R&D spend to continue building while the rebate was still in the processing pipeline. Trade Ledger, a fintech company, drew on R&D finance to keep its product development on track during a critical growth phase. Each of these businesses was already claiming the R&DTI. R&D finance didn’t change their eligibility or their claim. It changed the timing, giving them access to capital they’d already earned months before the ATO paid out.

You can read the full details on our case studies page.

Your R&D expenditure has already generated value, and R&D Tax Incentive financing lets you put that value to work now rather than six to 12 months from now. Call our team on 0414 295 842 to talk through your situation, or if you’re ready to move, access your R&D rebate early and apply now.

Frequently asked questions

Do I need to have lodged my R&DTI claim before accessing R&D finance?

No. Rocking Horse lends against eligible R&D expenditure your company has already incurred during the current financial year, confirmed by a comfort letter from your R&D tax consultant. You can access R&D finance well before your claim is lodged with the ATO, and many businesses do exactly that so they can put the capital to work during the year rather than after it.

Can I use R&D finance for expenses outside of R&D?

Yes. There are no restrictions on how R&D finance funds are used. While the loan is secured against your R&D expenditure and expected R&DTI rebate, the capital itself can go toward any business purpose, whether that’s hiring, marketing, operational costs, further development, or something else entirely. How you deploy the funds is your decision.

What happens if my R&DTI claim is reduced after I’ve received the finance?

The loan amount is based on your year-to-date eligible R&D expenditure as confirmed by your R&D tax consultant. If your final claim amount changes, the Rocking Horse team works with you to manage the adjustment. This is one reason the comfort letter from an independent R&D advisor is a core part of the process, because it provides a verified and conservative basis for the advance rather than relying on estimates.

Is R&D finance only for startups?

No. R&D Tax Incentive financing is available from $50,000 to $10 million, covering early-stage startups through to large enterprises. Any Australian company that’s eligible for the R&DTI and has incurred eligible R&D expenditure during the current financial year can explore R&D finance, regardless of size or industry. The product is just as relevant for a scaling SaaS company as it is for a biotech firm running multi-year clinical trials.

How quickly can I receive funds?

Funds are typically delivered within two weeks of approval. The timeline depends on how quickly you can gather supporting documents, including the comfort letter from your R&D tax consultant, and confirm your ATO position. For businesses that have their documentation in order and an established R&D claim history, the process moves quickly.